---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-004280"
form_type: "8-K"
ticker: "APYP"
cik: "0001568969"
company_name: "APPYEA, INC"
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T18:00:58.069614+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AppYea appoints Ron Mekler to board and audit committee; grants options for 500,000 shares

## Summary
- Ron Mekler appointed as director on Jan 26, 2023; also joins Audit Committee.
- Mekler is CFO of Clalit Health Services, Israel's largest health organization.
- Receives options for 500,000 shares at par value, vesting 50% after 1 year then quarterly.
- No family relationships or related-party transactions with the company or its officers.

## SEC filing metadata
- accession: 0001493152-23-004280
- form_type: 8-K
- ticker: APYP
- cik: 0001568969
- company_name: APPYEA, INC
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568969/000149315223004280/0001493152-23-004280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568969/000149315223004280/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-004280
- JSON: https://secwatch.observer/filing/0001493152-23-004280.json
- Plain text: https://secwatch.observer/filing/0001493152-23-004280.txt

## Key facts
- Executive change
  Ron Mekler was appointed as Director at APPYEA, INC.
  - Action: appointed
  - Role: Director
  source text: On January 26, 2023, the board of directors (the “Board”) of AppYea, Inc. (“AppYea”) appointed Ron Mekler as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568969/000149315223004280/0001493152-23-004280-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.